Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
A Phase 1 Trial of Dose-Escalated Hypofractionated Adaptive Radiation Therapy With Atezolizumab for Advanced Head and Neck Cancers.
Journal: International journal of radiation oncology, biology, physics
Published: January 21, 2026
Radiation-induced remodeling of the T cell landscape in head and neck cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: December 10, 2025
Multiomic Selection of Cancer-Testis Antigens as Precision Immuno-oncologic Targets in Head and Neck Cancer.
Journal: JAMA otolaryngology-- head & neck surgery
Published: October 23, 2025
CXCR2 Blockade Improves Response to Hypo-fractionated Radiation Treatment in a Murine Head and Neck Squamous Cell Carcinoma (HNSCC) Model.
Journal: Radiation research
Published: August 27, 2025
Radiation-Induced Loss of Tumor-Reactive T Cells Calls for More Rationally Designed Radioimmunotherapy Approaches.
Journal: International journal of radiation oncology, biology, physics
Published: August 01, 2025
Tumoral Skin Invasion Is an Independent Predictor of Rapid Recurrence in Head and Neck Cancer.
Journal: Head & neck
Published: July 03, 2025
Radiation therapy results in preferential tumor antigen-specific lymphodepletion in head and neck cancer.
Journal: Nature communications
Published: October 15, 2024
Locked Dimerized CXCL12 Exerts Radiosensitizing Effects in Head and Neck Cancer.
Journal: Head & neck
Published: August 30, 2024
Corrigendum to Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture.
Journal: Translational oncology
Published: April 19, 2024
Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-culture.
Journal: Translational oncology
Published: November 30, 2023
Type I interferon signaling promotes radioresistance in head and neck cancer.
Journal: Translational cancer research
Published: November 15, 2023
Photoactivated HPPH-Liposomal therapy for the treatment of HPV-Negative head and neck cancer.
Journal: Oral oncology
Published: April 06, 2023
Last Updated: 09/26/2026